Toxicity of non-drug-containing liposomes for cultured human cells.

The effects of non-drug-containing liposomes of different compositions and sizes on the proliferation of nine cancer-derived and one normal cultured human cell lines were determined. Stearylamine- and cardiolipin-containing liposomes were toxic (ID50) at 200 microM liposomal lipid concentrations or less, whereas phosphatidylglycerol- and phosphatidylserine-containing liposomes were toxic in the range 130-3000 microM. Phosphatidylcholine or dipalmitoylphosphatidylcholine liposomes were not toxic at 3000-4000 microM. In general, small liposomes were more toxic than large ones. The results indicate that there are wide variations in toxicity of non-drug-containing liposomes for cultured human cells. The potential for nonspecific toxicity due to the liposomes themselves should be carefully considered if human administration of drug-containing liposomes is to be done.

[1]  F. Sala,et al.  Liposomes induce chromosome aberrations in human cultured cells. , 1985, Experimental cell research.

[2]  E. Hersh,et al.  Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer. , 1984, Cancer research.

[3]  H. Kimelberg,et al.  PROPERTIES AND BIOLOGICAL EFFECTS OF LIPOSOMES AND THEIR USES IN PHARMACOLOGY AND TOXICOLOGY , 1978 .

[4]  J. Roh,et al.  Comparative pharmacokinetics of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes. , 1986, Cancer research.

[5]  Y. Rustum,et al.  Inhibition of liver metastases of M 5076 tumor by liposome-entrapped adriamycin. , 1983, Cancer drug delivery.

[6]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[7]  T. Allen,et al.  Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution. , 1984, The Journal of pharmacology and experimental therapeutics.

[8]  M. Ito Microassay for studying anticellular effects of human interferons. , 1984, Journal of Interferon Research.

[9]  F. Szoka,et al.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. , 1980, Biochimica et biophysica acta.

[10]  M. Ito,et al.  Cytocidal effect of purified human fibroblast interferon on tumor cells in vitro. , 1981, Journal of the National Cancer Institute.

[11]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[12]  Y. Rustum,et al.  Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia. , 1979, Cancer research.

[13]  C. Bucana,et al.  Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. , 1982, Cancer research.